Recurrence Patterns After Surgical Resection of Gastroenteropancreatic Neuroendocrine Tumors

Autor: Emily K. Bergsland, Jonathan R. Strosberg, Manisha H. Shah, Hilary Chan, Matthew H. Kulke, Michael A. Choti, Al B. Benson, Mark Bloomston, James C. Yao, Li Zhang, Eric K. Nakakura, Katherine Van Loon
Rok vydání: 2021
Předmět:
Male
Oncology
Databases
Factual

Outcome Assessment
Endocrinology
Diabetes and Metabolism

Kaplan-Meier Estimate
Neuroendocrine tumors
New diagnosis
0302 clinical medicine
Endocrinology
Outcome Assessment
Health Care

80 and over
guidelines
Cancer
Aged
80 and over

Middle Aged
Primary tumor
Colo-Rectal Cancer
Neuroendocrine Tumors
medicine.anatomical_structure
Local
030220 oncology & carcinogenesis
surveillance
Female
030211 gastroenterology & hepatology
Patient Safety
Pancreas
Adult
Surgical resection
medicine.medical_specialty
recurrence
Clinical Sciences
MEDLINE
Rectum
Article
Databases
Young Adult
03 medical and health sciences
Rare Diseases
Stomach Neoplasms
Internal medicine
Intestinal Neoplasms
Internal Medicine
medicine
Humans
Factual
Aged
Gastroenterology & Hepatology
Hepatology
business.industry
medicine.disease
United States
Pancreatic Neoplasms
Health Care
Neoplasm Recurrence
Neoplasm Recurrence
Local

Digestive Diseases
business
Zdroj: Pancreas, vol 50, iss 4
Pancreas
ISSN: 1536-4828
0885-3177
Popis: Objective Current National Comprehensive Cancer Network guidelines for gastroenteropancreatic neuroendocrine tumors (GEPNETs) recommend complete (R0) surgical resection of the primary tumor and metastases, if feasible. However, large multicenter studies of recurrence patterns of GEPNETs after resection have not been performed. Methods Patients 18 years or older who presented to 7 participating National Comprehensive Cancer Network institutions between 2004 and 2008 with a new diagnosis of a small bowel, pancreas, or colon/rectum neuroendocrine tumor (NET) and underwent R0 resection of the primary tumor, and synchronous metastases, if present, were included in this analysis. Descriptive statistics and Kaplan-Meier estimates were used to calculate recurrence rates and time-associated end points, respectively. Results Of 294 patients with GEPNETs, 50% were male, 88% were White, and 99% had Eastern Cooperative Oncology Group performance status 0 to 1. The median age was 55 years (range, 20-90). The median follow-up time from R0 resection was 62.1 months. Recurrence rates were 18% in small bowel NETs (n = 110), 26% in pancreatic NETs (n = 141), and 10% in colon/rectum NETs (n = 50). The frequency of surveillance imaging was highly variable. Conclusions R0 resection was associated with variable risk of recurrence across subtypes. Further research to inform refinement of guidelines for the appropriate duration of surveillance after R0 resection is needed.
Databáze: OpenAIRE